

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.21186945 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.21186945 |
| 3 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.06013781 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 3.99280312 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 3.99280312 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.99280312 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.99280312 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.99280312 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 3.99280312 |
| 10 | apoptotic cell clearance (GO:0043277) | 3.84665527 |
| 11 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.84331271 |
| 12 | protein carboxylation (GO:0018214) | 3.84331271 |
| 13 | mannose metabolic process (GO:0006013) | 3.84214052 |
| 14 | barbed-end actin filament capping (GO:0051016) | 3.77193991 |
| 15 | adhesion of symbiont to host (GO:0044406) | 3.69132396 |
| 16 | complement activation, alternative pathway (GO:0006957) | 3.69064909 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 3.64655362 |
| 18 | glycosphingolipid catabolic process (GO:0046479) | 3.61709205 |
| 19 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.59250110 |
| 20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.54156702 |
| 21 | low-density lipoprotein particle clearance (GO:0034383) | 3.51680139 |
| 22 | detection of molecule of bacterial origin (GO:0032490) | 3.49678043 |
| 23 | regulation of extracellular matrix disassembly (GO:0010715) | 3.45823498 |
| 24 | virion attachment to host cell (GO:0019062) | 3.45722935 |
| 25 | adhesion of symbiont to host cell (GO:0044650) | 3.45722935 |
| 26 | protein localization to endosome (GO:0036010) | 3.44196653 |
| 27 | alpha-linolenic acid metabolic process (GO:0036109) | 3.43712546 |
| 28 | regulation of protein activation cascade (GO:2000257) | 3.37594728 |
| 29 | regulation of complement activation (GO:0030449) | 3.37271868 |
| 30 | tyrosine metabolic process (GO:0006570) | 3.36652912 |
| 31 | positive regulation of extracellular matrix organization (GO:1903055) | 3.33812565 |
| 32 | Golgi transport vesicle coating (GO:0048200) | 3.28635017 |
| 33 | COPI coating of Golgi vesicle (GO:0048205) | 3.28635017 |
| 34 | L-phenylalanine metabolic process (GO:0006558) | 3.27871866 |
| 35 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.27871866 |
| 36 | pinocytosis (GO:0006907) | 3.27728520 |
| 37 | glycolipid catabolic process (GO:0019377) | 3.26825363 |
| 38 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.26699937 |
| 39 | L-phenylalanine catabolic process (GO:0006559) | 3.26699937 |
| 40 | keratan sulfate catabolic process (GO:0042340) | 3.25270662 |
| 41 | plasma lipoprotein particle clearance (GO:0034381) | 3.24835702 |
| 42 | hyaluronan catabolic process (GO:0030214) | 3.24198353 |
| 43 | regulation of cholesterol storage (GO:0010885) | 3.23085932 |
| 44 | sulfur amino acid catabolic process (GO:0000098) | 3.18396265 |
| 45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.15399564 |
| 46 | skin morphogenesis (GO:0043589) | 3.15116529 |
| 47 | oligosaccharide catabolic process (GO:0009313) | 3.13939935 |
| 48 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.07003668 |
| 49 | regulation of early endosome to late endosome transport (GO:2000641) | 3.05050911 |
| 50 | opsonization (GO:0008228) | 3.02936749 |
| 51 | regulation of cholesterol esterification (GO:0010872) | 3.00997635 |
| 52 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.99535759 |
| 53 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.99535759 |
| 54 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.98674882 |
| 55 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.96636497 |
| 56 | regulation of apoptotic cell clearance (GO:2000425) | 2.94746829 |
| 57 | positive regulation of interferon-alpha production (GO:0032727) | 2.94152646 |
| 58 | amino sugar catabolic process (GO:0046348) | 2.92990669 |
| 59 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.90112197 |
| 60 | urea cycle (GO:0000050) | 2.86127855 |
| 61 | urea metabolic process (GO:0019627) | 2.86127855 |
| 62 | glyoxylate metabolic process (GO:0046487) | 2.85715239 |
| 63 | valine metabolic process (GO:0006573) | 2.84566081 |
| 64 | 4-hydroxyproline metabolic process (GO:0019471) | 2.83306355 |
| 65 | response to thyroid hormone (GO:0097066) | 2.82680414 |
| 66 | positive regulation of coagulation (GO:0050820) | 2.81787836 |
| 67 | stress fiber assembly (GO:0043149) | 2.81660976 |
| 68 | positive regulation of hemostasis (GO:1900048) | 2.81616578 |
| 69 | positive regulation of blood coagulation (GO:0030194) | 2.81616578 |
| 70 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.81470624 |
| 71 | aromatic amino acid family catabolic process (GO:0009074) | 2.80884358 |
| 72 | regulation of plasminogen activation (GO:0010755) | 2.78402635 |
| 73 | complement activation (GO:0006956) | 2.78000087 |
| 74 | negative regulation of fibrinolysis (GO:0051918) | 2.77758303 |
| 75 | regulation of interferon-alpha production (GO:0032647) | 2.75644162 |
| 76 | endodermal cell differentiation (GO:0035987) | 2.71907068 |
| 77 | cysteine metabolic process (GO:0006534) | 2.71564167 |
| 78 | response to laminar fluid shear stress (GO:0034616) | 2.71069665 |
| 79 | complement activation, classical pathway (GO:0006958) | 2.70597143 |
| 80 | ceramide catabolic process (GO:0046514) | 2.70505567 |
| 81 | regulation of extracellular matrix organization (GO:1903053) | 2.69703180 |
| 82 | amyloid precursor protein catabolic process (GO:0042987) | 2.65065240 |
| 83 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.64766668 |
| 84 | nitrogen cycle metabolic process (GO:0071941) | 2.59240194 |
| 85 | tooth mineralization (GO:0034505) | 2.58125176 |
| 86 | embryo implantation (GO:0007566) | 2.57504965 |
| 87 | cellular modified amino acid catabolic process (GO:0042219) | 2.56448742 |
| 88 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.55096918 |
| 89 | regulation of cholesterol homeostasis (GO:2000188) | 2.54836520 |
| 90 | positive regulation of cholesterol efflux (GO:0010875) | 2.54722810 |
| 91 | bile acid biosynthetic process (GO:0006699) | 2.54244027 |
| 92 | reverse cholesterol transport (GO:0043691) | 2.53950722 |
| 93 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.52908437 |
| 94 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.52553895 |
| 95 | high-density lipoprotein particle remodeling (GO:0034375) | 2.51917892 |
| 96 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.51536409 |
| 97 | aldehyde catabolic process (GO:0046185) | 2.51019968 |
| 98 | pentose-phosphate shunt (GO:0006098) | 2.50899822 |
| 99 | protein activation cascade (GO:0072376) | 2.50694335 |
| 100 | sphingolipid catabolic process (GO:0030149) | 2.49474625 |
| 101 | membrane lipid catabolic process (GO:0046466) | 2.48786057 |
| 102 | macrophage activation (GO:0042116) | 2.48670398 |
| 103 | kynurenine metabolic process (GO:0070189) | 2.48038017 |
| 104 | melanin biosynthetic process (GO:0042438) | 2.47754454 |
| 105 | negative regulation of fatty acid transport (GO:2000192) | 2.47748224 |
| 106 | ethanol oxidation (GO:0006069) | 2.46925262 |
| 107 | regulation of fibrinolysis (GO:0051917) | 2.46845226 |
| 108 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.45447204 |
| 109 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.44731760 |
| 110 | cell adhesion mediated by integrin (GO:0033627) | 2.44117630 |
| 111 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.43504947 |
| 112 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.43113887 |
| 113 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.42897442 |
| 114 | response to host immune response (GO:0052572) | 2.42897442 |
| 115 | fibrinolysis (GO:0042730) | 2.42810535 |
| 116 | NADPH regeneration (GO:0006740) | 2.42730443 |
| 117 | N-acetylneuraminate metabolic process (GO:0006054) | 2.42550906 |
| 118 | positive regulation of receptor recycling (GO:0001921) | 2.42541676 |
| 119 | lipoprotein metabolic process (GO:0042157) | 2.42090707 |
| 120 | peptide catabolic process (GO:0043171) | 2.41692693 |
| 121 | cholesterol efflux (GO:0033344) | 2.41443151 |
| 122 | lysine metabolic process (GO:0006553) | 2.41322877 |
| 123 | lysine catabolic process (GO:0006554) | 2.41322877 |
| 124 | 2-oxoglutarate metabolic process (GO:0006103) | 2.41141961 |
| 125 | protein heterotrimerization (GO:0070208) | 2.41054228 |
| 126 | tryptophan metabolic process (GO:0006568) | 2.40498182 |
| 127 | acute-phase response (GO:0006953) | 2.40210553 |
| 128 | amino-acid betaine metabolic process (GO:0006577) | 2.40015636 |
| 129 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.39176880 |
| 130 | homocysteine metabolic process (GO:0050667) | 2.38759576 |
| 131 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.38240843 |
| 132 | indole-containing compound catabolic process (GO:0042436) | 2.37946983 |
| 133 | indolalkylamine catabolic process (GO:0046218) | 2.37946983 |
| 134 | tryptophan catabolic process (GO:0006569) | 2.37946983 |
| 135 | basement membrane organization (GO:0071711) | 2.37755372 |
| 136 | aromatic amino acid family metabolic process (GO:0009072) | 2.37350469 |
| 137 | phospholipid efflux (GO:0033700) | 2.37149385 |
| 138 | epithelial cell-cell adhesion (GO:0090136) | 2.37138356 |
| 139 | protein retention in ER lumen (GO:0006621) | 2.37101634 |
| 140 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.36510701 |
| 141 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.35976516 |
| 142 | negative regulation of lipid transport (GO:0032369) | 2.35677966 |
| 143 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.35290497 |
| 144 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.34384237 |
| 145 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.34193345 |
| 146 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.34092762 |
| 147 | neutrophil activation involved in immune response (GO:0002283) | 2.33064389 |
| 148 | bile acid metabolic process (GO:0008206) | 2.32714406 |
| 149 | protein-lipid complex assembly (GO:0065005) | 2.32101859 |
| 150 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.31170969 |
| 151 | glucose 6-phosphate metabolic process (GO:0051156) | 2.30231981 |
| 152 | hyaluronan metabolic process (GO:0030212) | 2.29154647 |
| 153 | cell migration involved in heart development (GO:0060973) | 2.28501041 |
| 154 | collagen metabolic process (GO:0032963) | 2.27979828 |
| 155 | plasma lipoprotein particle assembly (GO:0034377) | 2.27753761 |
| 156 | proline biosynthetic process (GO:0006561) | 2.27294654 |
| 157 | modulation by symbiont of host cellular process (GO:0044068) | 2.26649684 |
| 158 | regulation of mononuclear cell migration (GO:0071675) | 2.25298951 |
| 159 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.24594043 |
| 160 | glucose catabolic process (GO:0006007) | 2.23694295 |
| 161 | decidualization (GO:0046697) | 2.23584280 |
| 162 | semaphorin-plexin signaling pathway (GO:0071526) | 2.23425606 |
| 163 | glial cell migration (GO:0008347) | 2.22774099 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.54955760 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.05286208 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.93598950 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.71466632 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.39770551 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.38445601 |
| 7 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.25426895 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.70981974 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.66297051 |
| 10 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.56009606 |
| 11 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.52693614 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.42852789 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.40318797 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.37526679 |
| 15 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.36873473 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.32062948 |
| 17 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.25864708 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.19448154 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.16301696 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.04574685 |
| 21 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.04049661 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.01737377 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.99503047 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.98311177 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.96910085 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.96581983 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.95527505 |
| 28 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90052999 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.81938558 |
| 30 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.79757115 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.76342960 |
| 32 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.71619483 |
| 33 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.68508873 |
| 34 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.68062120 |
| 35 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.67845796 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.67215611 |
| 37 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65956172 |
| 38 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.63478718 |
| 39 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.61599272 |
| 40 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.59364531 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51373222 |
| 42 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.51303077 |
| 43 | KDM2B_26808549_Chip-Seq_K562_Human | 1.49191499 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49078935 |
| 45 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.48077889 |
| 46 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.47039372 |
| 47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.45042443 |
| 48 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42725469 |
| 49 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40863174 |
| 50 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.39142420 |
| 51 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37182939 |
| 52 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.36678585 |
| 53 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36383865 |
| 54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.35274044 |
| 55 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.35155247 |
| 56 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.35028914 |
| 57 | MAF_26560356_Chip-Seq_TH1_Human | 1.32575919 |
| 58 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.32456770 |
| 59 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.32201890 |
| 60 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.31453354 |
| 61 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.28762462 |
| 62 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28702415 |
| 63 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.28392853 |
| 64 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.26871256 |
| 65 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.25589545 |
| 66 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.24074339 |
| 67 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23348620 |
| 68 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23286492 |
| 69 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.23101810 |
| 70 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.23081052 |
| 71 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22888788 |
| 72 | ATF3_27146783_Chip-Seq_COLON_Human | 1.22691021 |
| 73 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.22433916 |
| 74 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.22363167 |
| 75 | P68_20966046_ChIP-Seq_HELA_Human | 1.21985553 |
| 76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20892309 |
| 77 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.19469424 |
| 78 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.18673409 |
| 79 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.18665457 |
| 80 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.18275926 |
| 81 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17802145 |
| 82 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17486924 |
| 83 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.17479115 |
| 84 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.16972543 |
| 85 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.16788201 |
| 86 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.16557795 |
| 87 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.15678423 |
| 88 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.13746239 |
| 89 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.13111891 |
| 90 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.13018048 |
| 91 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.12571364 |
| 92 | MYC_22102868_ChIP-Seq_BL_Human | 1.10964102 |
| 93 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.10758526 |
| 94 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.10596760 |
| 95 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10224532 |
| 96 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09806516 |
| 97 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.08358144 |
| 98 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.08198232 |
| 99 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.08046964 |
| 100 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.07516401 |
| 101 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.06825014 |
| 102 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05513257 |
| 103 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.05337670 |
| 104 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.04859803 |
| 105 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.04762195 |
| 106 | UTX_26944678_Chip-Seq_JUKART_Human | 1.04742911 |
| 107 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.04040866 |
| 108 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.03743210 |
| 109 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03299437 |
| 110 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.01735670 |
| 111 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.01728263 |
| 112 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.01557933 |
| 113 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.01382781 |
| 114 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.01374229 |
| 115 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01042689 |
| 116 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.00859063 |
| 117 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00628479 |
| 118 | MYB_26560356_Chip-Seq_TH2_Human | 1.00150579 |
| 119 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.00076192 |
| 120 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.99832599 |
| 121 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99740603 |
| 122 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.99221130 |
| 123 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.99070615 |
| 124 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.99047417 |
| 125 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97225412 |
| 126 | * TFEB_21752829_ChIP-Seq_HELA_Human | 0.96877642 |
| 127 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.96681371 |
| 128 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.94871250 |
| 129 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.94702214 |
| 130 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94252992 |
| 131 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93434377 |
| 132 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93408906 |
| 133 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93182863 |
| 134 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93150793 |
| 135 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92838752 |
| 136 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.92699840 |
| 137 | * MYB_26560356_Chip-Seq_TH1_Human | 0.92692211 |
| 138 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91392434 |
| 139 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.91290603 |
| 140 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89940781 |
| 141 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89660469 |
| 142 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.89405085 |
| 143 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.89256005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0005058_abnormal_lysosome_morphology | 3.60376675 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.52724332 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.34924554 |
| 4 | MP0009840_abnormal_foam_cell | 3.23084067 |
| 5 | MP0005360_urolithiasis | 3.17911594 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.93374484 |
| 7 | MP0003172_abnormal_lysosome_physiology | 2.59805670 |
| 8 | MP0005365_abnormal_bile_salt | 2.57790651 |
| 9 | MP0006082_CNS_inflammation | 2.49420988 |
| 10 | MP0003705_abnormal_hypodermis_morpholog | 2.42803683 |
| 11 | MP0005451_abnormal_body_composition | 2.35681208 |
| 12 | MP0004272_abnormal_basement_membrane | 2.20194037 |
| 13 | MP0003436_decreased_susceptibility_to | 2.18420400 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.17447933 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.10940704 |
| 16 | MP0003303_peritoneal_inflammation | 2.05558639 |
| 17 | MP0005085_abnormal_gallbladder_physiolo | 2.04259159 |
| 18 | MP0003252_abnormal_bile_duct | 2.00954084 |
| 19 | MP0001835_abnormal_antigen_presentation | 1.99125651 |
| 20 | MP0005257_abnormal_intraocular_pressure | 1.90040724 |
| 21 | MP0001958_emphysema | 1.84993539 |
| 22 | MP0002419_abnormal_innate_immunity | 1.78939148 |
| 23 | MP0004858_abnormal_nervous_system | 1.78594549 |
| 24 | MP0010329_abnormal_lipoprotein_level | 1.73272408 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.72731813 |
| 26 | MP0005503_abnormal_tendon_morphology | 1.68335018 |
| 27 | MP0003195_calcinosis | 1.65876879 |
| 28 | MP0005083_abnormal_biliary_tract | 1.62792792 |
| 29 | MP0003724_increased_susceptibility_to | 1.58924955 |
| 30 | MP0003329_amyloid_beta_deposits | 1.57346884 |
| 31 | MP0008260_abnormal_autophagy | 1.56767988 |
| 32 | MP0001533_abnormal_skeleton_physiology | 1.56648245 |
| 33 | MP0003091_abnormal_cell_migration | 1.54900917 |
| 34 | MP0000604_amyloidosis | 1.51698224 |
| 35 | MP0003566_abnormal_cell_adhesion | 1.46951024 |
| 36 | MP0000609_abnormal_liver_physiology | 1.45804021 |
| 37 | MP0009384_cardiac_valve_regurgitation | 1.44318538 |
| 38 | MP0005387_immune_system_phenotype | 1.41207504 |
| 39 | MP0001790_abnormal_immune_system | 1.41207504 |
| 40 | MP0009643_abnormal_urine_homeostasis | 1.40802006 |
| 41 | MP0003453_abnormal_keratinocyte_physiol | 1.39256292 |
| 42 | MP0003279_aneurysm | 1.37899535 |
| 43 | MP0004510_myositis | 1.36115396 |
| 44 | MP0008469_abnormal_protein_level | 1.35291898 |
| 45 | MP0001542_abnormal_bone_strength | 1.34576784 |
| 46 | MP0005332_abnormal_amino_acid | 1.33775880 |
| 47 | MP0005025_abnormal_response_to | 1.33377478 |
| 48 | MP0000685_abnormal_immune_system | 1.33371596 |
| 49 | MP0000372_irregular_coat_pigmentation | 1.32949248 |
| 50 | MP0006054_spinal_hemorrhage | 1.32600229 |
| 51 | MP0002998_abnormal_bone_remodeling | 1.31910952 |
| 52 | MP0005000_abnormal_immune_tolerance | 1.27635828 |
| 53 | MP0009785_altered_susceptibility_to | 1.26665869 |
| 54 | MP0002254_reproductive_system_inflammat | 1.25337600 |
| 55 | MP0000371_diluted_coat_color | 1.24615967 |
| 56 | MP0005670_abnormal_white_adipose | 1.24298111 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.23002979 |
| 58 | MP0005076_abnormal_cell_differentiation | 1.21589713 |
| 59 | MP0002452_abnormal_antigen_presenting | 1.20337910 |
| 60 | MP0004019_abnormal_vitamin_homeostasis | 1.19735165 |
| 61 | MP0005319_abnormal_enzyme/_coenzyme | 1.19559148 |
| 62 | MP0004947_skin_inflammation | 1.19297640 |
| 63 | MP0002118_abnormal_lipid_homeostasis | 1.18082712 |
| 64 | MP0002060_abnormal_skin_morphology | 1.17702389 |
| 65 | MP0002138_abnormal_hepatobiliary_system | 1.17630134 |
| 66 | MP0003075_altered_response_to | 1.14566434 |
| 67 | MP0002877_abnormal_melanocyte_morpholog | 1.12171856 |
| 68 | MP0005023_abnormal_wound_healing | 1.12090889 |
| 69 | MP0002896_abnormal_bone_mineralization | 1.10302390 |
| 70 | MP0005275_abnormal_skin_tensile | 1.09560410 |
| 71 | MP0009764_decreased_sensitivity_to | 1.09556022 |
| 72 | MP0000343_altered_response_to | 1.09081176 |
| 73 | MP0005408_hypopigmentation | 1.08143152 |
| 74 | MP0002148_abnormal_hypersensitivity_rea | 1.07341925 |
| 75 | MP0002933_joint_inflammation | 1.07132341 |
| 76 | MP0000003_abnormal_adipose_tissue | 1.05832471 |
| 77 | MP0010368_abnormal_lymphatic_system | 1.05518626 |
| 78 | MP0003806_abnormal_nucleotide_metabolis | 1.05174464 |
| 79 | MP0001666_abnormal_nutrient_absorption | 1.05171204 |
| 80 | * MP0000598_abnormal_liver_morphology | 1.04440263 |
| 81 | MP0001800_abnormal_humoral_immune | 1.04135663 |
| 82 | MP0010234_abnormal_vibrissa_follicle | 1.03712834 |
| 83 | MP0002723_abnormal_immune_serum | 1.03668921 |
| 84 | MP0005375_adipose_tissue_phenotype | 1.01857618 |
| 85 | MP0005508_abnormal_skeleton_morphology | 1.00818813 |
| 86 | MP0003183_abnormal_peptide_metabolism | 0.99527720 |
| 87 | MP0000465_gastrointestinal_hemorrhage | 0.99346883 |
| 88 | MP0002136_abnormal_kidney_physiology | 0.97431201 |
| 89 | MP0003690_abnormal_glial_cell | 0.97224723 |
| 90 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96130285 |
| 91 | MP0003186_abnormal_redox_activity | 0.95406935 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.94908494 |
| 93 | MP0002089_abnormal_postnatal_growth/wei | 0.94352487 |
| 94 | MP0005409_darkened_coat_color | 0.93332915 |
| 95 | MP0009278_abnormal_bone_marrow | 0.93300485 |
| 96 | MP0001243_abnormal_dermal_layer | 0.92528143 |
| 97 | MP0001915_intracranial_hemorrhage | 0.92243117 |
| 98 | MP0005166_decreased_susceptibility_to | 0.92229030 |
| 99 | MP0000249_abnormal_blood_vessel | 0.92060576 |
| 100 | MP0001756_abnormal_urination | 0.91998802 |
| 101 | MP0005164_abnormal_response_to | 0.91850845 |
| 102 | MP0001853_heart_inflammation | 0.91814269 |
| 103 | MP0000681_abnormal_thyroid_gland | 0.91619123 |
| 104 | MP0001819_abnormal_immune_cell | 0.91485108 |
| 105 | MP0002295_abnormal_pulmonary_circulatio | 0.91452535 |
| 106 | MP0002090_abnormal_vision | 0.91433743 |
| 107 | MP0002420_abnormal_adaptive_immunity | 0.90858863 |
| 108 | MP0005165_increased_susceptibility_to | 0.90093441 |
| 109 | * MP0001849_ear_inflammation | 0.89856679 |
| 110 | MP0001661_extended_life_span | 0.89128987 |
| 111 | MP0003448_altered_tumor_morphology | 0.87235120 |
| 112 | MP0005666_abnormal_adipose_tissue | 0.87170489 |
| 113 | MP0005220_abnormal_exocrine_pancreas | 0.86867743 |
| 114 | MP0009763_increased_sensitivity_to | 0.85957631 |
| 115 | MP0003634_abnormal_glial_cell | 0.85162514 |
| 116 | MP0000751_myopathy | 0.84975620 |
| 117 | MP0000858_altered_metastatic_potential | 0.84766991 |
| 118 | MP0010307_abnormal_tumor_latency | 0.84498115 |
| 119 | MP0003795_abnormal_bone_structure | 0.84258344 |
| 120 | MP0001851_eye_inflammation | 0.83606156 |
| 121 | MP0005390_skeleton_phenotype | 0.82597033 |
| 122 | MP0002405_respiratory_system_inflammati | 0.82317231 |
| 123 | MP0009333_abnormal_splenocyte_physiolog | 0.82129041 |
| 124 | MP0005623_abnormal_meninges_morphology | 0.80791931 |
| 125 | MP0010155_abnormal_intestine_physiology | 0.80147335 |
| 126 | MP0000767_abnormal_smooth_muscle | 0.80136431 |
| 127 | MP0005595_abnormal_vascular_smooth | 0.79425515 |
| 128 | MP0002166_altered_tumor_susceptibility | 0.79002439 |
| 129 | MP0000569_abnormal_digit_pigmentation | 0.78621733 |
| 130 | MP0004233_abnormal_muscle_weight | 0.77496584 |
| 131 | MP0002168_other_aberrant_phenotype | 0.76536455 |
| 132 | MP0004185_abnormal_adipocyte_glucose | 0.75675846 |
| 133 | MP0004130_abnormal_muscle_cell | 0.75507330 |
| 134 | MP0002971_abnormal_brown_adipose | 0.74671475 |
| 135 | * MP0002135_abnormal_kidney_morphology | 0.74492323 |
| 136 | MP0005171_absent_coat_pigmentation | 0.72197413 |
| 137 | MP0004883_abnormal_blood_vessel | 0.71585540 |
| 138 | MP0005397_hematopoietic_system_phenotyp | 0.69611395 |
| 139 | MP0001545_abnormal_hematopoietic_system | 0.69611395 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 5.20906549 |
| 2 | Vacuolated lymphocytes (HP:0001922) | 4.78868182 |
| 3 | * Dysostosis multiplex (HP:0000943) | 4.55174357 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 4.54426423 |
| 5 | * Mucopolysacchariduria (HP:0008155) | 4.14337095 |
| 6 | * Urinary glycosaminoglycan excretion (HP:0003541) | 4.14337095 |
| 7 | Complement deficiency (HP:0004431) | 4.02837651 |
| 8 | * Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.88815363 |
| 9 | * Abnormality of polysaccharide metabolism (HP:0011012) | 3.88815363 |
| 10 | * Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.88815363 |
| 11 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.85330068 |
| 12 | Glomerulonephritis (HP:0000099) | 3.75315121 |
| 13 | Deep venous thrombosis (HP:0002625) | 3.56695928 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 3.52120324 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.52120324 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.52120324 |
| 17 | Abnormality of complement system (HP:0005339) | 3.38264607 |
| 18 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.20846919 |
| 19 | Xanthomatosis (HP:0000991) | 3.20831866 |
| 20 | Myocardial infarction (HP:0001658) | 3.18810558 |
| 21 | Loss of speech (HP:0002371) | 3.17276176 |
| 22 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.08687556 |
| 23 | Cerebral aneurysm (HP:0004944) | 3.00325295 |
| 24 | Axonal loss (HP:0003447) | 2.87537767 |
| 25 | Recurrent abscess formation (HP:0002722) | 2.85952473 |
| 26 | Eczematoid dermatitis (HP:0000976) | 2.83200307 |
| 27 | Cervical subluxation (HP:0003308) | 2.77160524 |
| 28 | Premature rupture of membranes (HP:0001788) | 2.75263277 |
| 29 | Abnormality of macrophages (HP:0004311) | 2.74392477 |
| 30 | Nephritis (HP:0000123) | 2.72943119 |
| 31 | Joint hemorrhage (HP:0005261) | 2.72746720 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 2.72200796 |
| 33 | Protrusio acetabuli (HP:0003179) | 2.66513947 |
| 34 | Nuclear cataract (HP:0100018) | 2.66477129 |
| 35 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.64804690 |
| 36 | Ankle contracture (HP:0006466) | 2.64208321 |
| 37 | Achilles tendon contracture (HP:0001771) | 2.62685584 |
| 38 | Abnormality of the Achilles tendon (HP:0005109) | 2.59259201 |
| 39 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.58263214 |
| 40 | Thin bony cortex (HP:0002753) | 2.57283005 |
| 41 | Aortic aneurysm (HP:0004942) | 2.53722214 |
| 42 | J-shaped sella turcica (HP:0002680) | 2.51483451 |
| 43 | Spondylolisthesis (HP:0003302) | 2.49724732 |
| 44 | Intrahepatic cholestasis (HP:0001406) | 2.49022008 |
| 45 | Biconcave vertebral bodies (HP:0004586) | 2.48426083 |
| 46 | Abnormality of the common coagulation pathway (HP:0010990) | 2.46870766 |
| 47 | Blue sclerae (HP:0000592) | 2.46467515 |
| 48 | Vertebral compression fractures (HP:0002953) | 2.44416344 |
| 49 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.41425123 |
| 50 | Neurofibrillary tangles (HP:0002185) | 2.39321194 |
| 51 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.37976312 |
| 52 | Aortic dissection (HP:0002647) | 2.33826872 |
| 53 | Wormian bones (HP:0002645) | 2.33698155 |
| 54 | Retinal atrophy (HP:0001105) | 2.32602640 |
| 55 | Hemorrhage of the eye (HP:0011885) | 2.28867694 |
| 56 | Peritonitis (HP:0002586) | 2.28743320 |
| 57 | Mitral stenosis (HP:0001718) | 2.27770762 |
| 58 | * Asymmetric septal hypertrophy (HP:0001670) | 2.26330297 |
| 59 | Abnormality of proline metabolism (HP:0010907) | 2.22580547 |
| 60 | Hydroxyprolinuria (HP:0003080) | 2.22580547 |
| 61 | Upper limb amyotrophy (HP:0009129) | 2.20273961 |
| 62 | Distal upper limb amyotrophy (HP:0007149) | 2.20273961 |
| 63 | Prolonged partial thromboplastin time (HP:0003645) | 2.18154818 |
| 64 | Fragile skin (HP:0001030) | 2.17628965 |
| 65 | Bladder diverticulum (HP:0000015) | 2.15347573 |
| 66 | Spinal rigidity (HP:0003306) | 2.14925158 |
| 67 | Hypoalphalipoproteinemia (HP:0003233) | 2.14834277 |
| 68 | Interstitial pulmonary disease (HP:0006530) | 2.14223996 |
| 69 | Beaking of vertebral bodies (HP:0004568) | 2.13927633 |
| 70 | Abnormality of the intrinsic pathway (HP:0010989) | 2.13916948 |
| 71 | Arterial tortuosity (HP:0005116) | 2.13457244 |
| 72 | Abnormality of the nasal mucosa (HP:0000433) | 2.13308853 |
| 73 | Thoracic kyphosis (HP:0002942) | 2.12921763 |
| 74 | Gingival bleeding (HP:0000225) | 2.12705988 |
| 75 | Dilatation of the ascending aorta (HP:0005111) | 2.12057503 |
| 76 | Cerebral inclusion bodies (HP:0100314) | 2.12019702 |
| 77 | Hyperlipoproteinemia (HP:0010980) | 2.11647412 |
| 78 | Vascular tortuosity (HP:0004948) | 2.11354728 |
| 79 | Ulnar bowing (HP:0003031) | 2.10161559 |
| 80 | Increased variability in muscle fiber diameter (HP:0003557) | 2.10031676 |
| 81 | Increased CSF protein (HP:0002922) | 2.09664775 |
| 82 | Abnormality of dentin (HP:0010299) | 2.06756415 |
| 83 | Purpura (HP:0000979) | 2.06651849 |
| 84 | Global brain atrophy (HP:0002283) | 2.06594948 |
| 85 | Skin nodule (HP:0200036) | 2.06431079 |
| 86 | Ketosis (HP:0001946) | 2.06148992 |
| 87 | Increased connective tissue (HP:0009025) | 2.03977024 |
| 88 | Atrophic scars (HP:0001075) | 2.03807248 |
| 89 | Nasal polyposis (HP:0100582) | 2.03733030 |
| 90 | Genu recurvatum (HP:0002816) | 2.03715087 |
| 91 | Impaired platelet aggregation (HP:0003540) | 2.01298098 |
| 92 | Abnormal platelet function (HP:0011869) | 2.01298098 |
| 93 | Hematochezia (HP:0002573) | 2.01214934 |
| 94 | Hypoglycemic coma (HP:0001325) | 2.01098563 |
| 95 | Abnormality of the lumbar spine (HP:0100712) | 2.00288925 |
| 96 | Pathologic fracture (HP:0002756) | 2.00110926 |
| 97 | Menorrhagia (HP:0000132) | 1.99911310 |
| 98 | Hyperacusis (HP:0010780) | 1.99499168 |
| 99 | Amyloidosis (HP:0011034) | 1.99388300 |
| 100 | Broad metatarsal (HP:0001783) | 1.98683291 |
| 101 | Protuberant abdomen (HP:0001538) | 1.96211176 |
| 102 | Autoimmune thrombocytopenia (HP:0001973) | 1.96092412 |
| 103 | Striae distensae (HP:0001065) | 1.95888604 |
| 104 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.95587240 |
| 105 | * Ovoid vertebral bodies (HP:0003300) | 1.95423034 |
| 106 | Prolonged neonatal jaundice (HP:0006579) | 1.94680754 |
| 107 | Short nail (HP:0001799) | 1.94471081 |
| 108 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.93669451 |
| 109 | Mitral regurgitation (HP:0001653) | 1.93275573 |
| 110 | Bone pain (HP:0002653) | 1.92591548 |
| 111 | Abnormality of purine metabolism (HP:0004352) | 1.92490185 |
| 112 | Soft skin (HP:0000977) | 1.92418327 |
| 113 | Abnormality of the acetabulum (HP:0003170) | 1.91705619 |
| 114 | Elbow flexion contracture (HP:0002987) | 1.90648386 |
| 115 | Esophageal varix (HP:0002040) | 1.90067947 |
| 116 | Shallow orbits (HP:0000586) | 1.89146673 |
| 117 | Nonimmune hydrops fetalis (HP:0001790) | 1.88765627 |
| 118 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.88591378 |
| 119 | Osteolytic defects of the hand bones (HP:0009699) | 1.88424319 |
| 120 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.88424319 |
| 121 | Conjunctival telangiectasia (HP:0000524) | 1.87600131 |
| 122 | Hypercholesterolemia (HP:0003124) | 1.85317182 |
| 123 | Distal lower limb muscle weakness (HP:0009053) | 1.85103099 |
| 124 | Emphysema (HP:0002097) | 1.82946407 |
| 125 | Sensorimotor neuropathy (HP:0007141) | 1.82270141 |
| 126 | Aneurysm (HP:0002617) | 1.81817312 |
| 127 | Long toe (HP:0010511) | 1.81770772 |
| 128 | Spontaneous hematomas (HP:0007420) | 1.79692564 |
| 129 | Aortic regurgitation (HP:0001659) | 1.79690950 |
| 130 | Gingivitis (HP:0000230) | 1.79597748 |
| 131 | Hand muscle atrophy (HP:0009130) | 1.79214637 |
| 132 | Recurrent skin infections (HP:0001581) | 1.78960527 |
| 133 | Ketoacidosis (HP:0001993) | 1.78568238 |
| 134 | Coxa vara (HP:0002812) | 1.78527599 |
| 135 | Generalized amyotrophy (HP:0003700) | 1.78446783 |
| 136 | Abnormality of iron homeostasis (HP:0011031) | 1.77831233 |
| 137 | Abnormality of the thoracic spine (HP:0100711) | 1.76549682 |
| 138 | Increased serum ferritin (HP:0003281) | 1.76544393 |
| 139 | Flared iliac wings (HP:0002869) | 1.75865814 |
| 140 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.75745108 |
| 141 | Colitis (HP:0002583) | 1.75519518 |
| 142 | * Joint stiffness (HP:0001387) | 1.75488609 |
| 143 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.75317345 |
| 144 | Stridor (HP:0010307) | 1.74987743 |
| 145 | Malnutrition (HP:0004395) | 1.74774754 |
| 146 | Upper motor neuron abnormality (HP:0002127) | 1.70233913 |
| 147 | Hypertriglyceridemia (HP:0002155) | 1.70142192 |
| 148 | Broad face (HP:0000283) | 1.69428123 |
| 149 | Flat acetabular roof (HP:0003180) | 1.67347281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.96482125 |
| 2 | TRIB3 | 4.28352736 |
| 3 | PKN2 | 3.28974814 |
| 4 | TGFBR2 | 3.13341458 |
| 5 | MST1R | 3.02924759 |
| 6 | PRPF4B | 2.54574475 |
| 7 | TBK1 | 2.41864704 |
| 8 | KIT | 2.31147650 |
| 9 | TYK2 | 2.13987259 |
| 10 | ICK | 2.13884939 |
| 11 | MAP4K1 | 2.10730396 |
| 12 | BLK | 2.08946601 |
| 13 | SMG1 | 2.05796209 |
| 14 | PTK6 | 1.92815185 |
| 15 | SIK1 | 1.89921872 |
| 16 | BCKDK | 1.89011419 |
| 17 | TAOK3 | 1.86022574 |
| 18 | MAPK15 | 1.81906865 |
| 19 | MAP2K3 | 1.80084088 |
| 20 | FGFR4 | 1.73918844 |
| 21 | TAOK2 | 1.64874675 |
| 22 | EPHB1 | 1.63852365 |
| 23 | ZAP70 | 1.60581187 |
| 24 | TTN | 1.56005252 |
| 25 | FLT3 | 1.55779800 |
| 26 | IRAK3 | 1.53336134 |
| 27 | EEF2K | 1.53026163 |
| 28 | CAMK1D | 1.50470058 |
| 29 | CDC42BPA | 1.48606992 |
| 30 | LRRK2 | 1.43179831 |
| 31 | JAK1 | 1.39370080 |
| 32 | CSF1R | 1.36592407 |
| 33 | JAK3 | 1.34701181 |
| 34 | PRKD2 | 1.32201105 |
| 35 | NME2 | 1.31502034 |
| 36 | SCYL2 | 1.30770165 |
| 37 | MAP3K3 | 1.30398759 |
| 38 | MET | 1.21639101 |
| 39 | RIPK1 | 1.21482694 |
| 40 | ARAF | 1.21480561 |
| 41 | CSK | 1.19971401 |
| 42 | BMX | 1.18679899 |
| 43 | MAP3K10 | 1.18016391 |
| 44 | PAK4 | 1.13292591 |
| 45 | TESK2 | 1.12646492 |
| 46 | EPHA2 | 1.11131598 |
| 47 | EPHA3 | 1.09517913 |
| 48 | KDR | 1.08687056 |
| 49 | NEK9 | 1.08077614 |
| 50 | BTK | 1.05332618 |
| 51 | JAK2 | 1.03335485 |
| 52 | CAMK1G | 1.02490679 |
| 53 | IKBKE | 1.00426381 |
| 54 | MYLK | 0.99028011 |
| 55 | CDK12 | 0.96971649 |
| 56 | HCK | 0.94681738 |
| 57 | IRAK4 | 0.93654315 |
| 58 | TAOK1 | 0.92283391 |
| 59 | RPS6KA2 | 0.91765935 |
| 60 | MAP3K14 | 0.89918504 |
| 61 | EPHB2 | 0.89504652 |
| 62 | LMTK2 | 0.89070511 |
| 63 | PIK3CG | 0.88062374 |
| 64 | STK10 | 0.87125939 |
| 65 | PDGFRA | 0.87040790 |
| 66 | CAMKK2 | 0.84243451 |
| 67 | LIMK1 | 0.82098044 |
| 68 | MARK3 | 0.81317707 |
| 69 | MAP3K11 | 0.80909039 |
| 70 | RIPK4 | 0.80788925 |
| 71 | RPS6KA4 | 0.78421232 |
| 72 | TESK1 | 0.77653659 |
| 73 | SYK | 0.77482050 |
| 74 | IKBKB | 0.77332199 |
| 75 | ABL2 | 0.73788795 |
| 76 | MAP3K6 | 0.73588990 |
| 77 | PAK2 | 0.72242612 |
| 78 | LATS2 | 0.70718720 |
| 79 | NTRK1 | 0.70395950 |
| 80 | PIM2 | 0.68307206 |
| 81 | MAPK7 | 0.67736764 |
| 82 | PRKD3 | 0.65964454 |
| 83 | PTK2 | 0.65425265 |
| 84 | MARK2 | 0.63832744 |
| 85 | RPS6KL1 | 0.63787251 |
| 86 | RPS6KC1 | 0.63787251 |
| 87 | CAMKK1 | 0.62341335 |
| 88 | BRAF | 0.62102690 |
| 89 | MAP2K2 | 0.61936576 |
| 90 | PRKCH | 0.61170122 |
| 91 | PDPK1 | 0.61060060 |
| 92 | INSRR | 0.61057700 |
| 93 | MAPKAPK3 | 0.60029791 |
| 94 | ITK | 0.59912927 |
| 95 | RET | 0.59765018 |
| 96 | MAP3K1 | 0.57962010 |
| 97 | LYN | 0.57844383 |
| 98 | LCK | 0.57394481 |
| 99 | TGFBR1 | 0.56833899 |
| 100 | ILK | 0.56415387 |
| 101 | PDK2 | 0.56191371 |
| 102 | DAPK3 | 0.55946059 |
| 103 | DYRK1B | 0.54494633 |
| 104 | IRAK2 | 0.54468852 |
| 105 | GRK7 | 0.54253190 |
| 106 | DDR2 | 0.54236320 |
| 107 | HIPK2 | 0.52460889 |
| 108 | TYRO3 | 0.51366390 |
| 109 | TEC | 0.51089814 |
| 110 | MATK | 0.51044316 |
| 111 | PDK1 | 0.49742522 |
| 112 | IRAK1 | 0.49576872 |
| 113 | PRKG2 | 0.49147056 |
| 114 | CHUK | 0.48772599 |
| 115 | GSK3A | 0.48639834 |
| 116 | MAP3K8 | 0.47804634 |
| 117 | TRPM7 | 0.47633619 |
| 118 | EGFR | 0.47165149 |
| 119 | MAPK12 | 0.46497201 |
| 120 | MAPKAPK2 | 0.43943501 |
| 121 | MAP3K13 | 0.43346229 |
| 122 | MAPK4 | 0.42860510 |
| 123 | PDGFRB | 0.42860188 |
| 124 | GRK6 | 0.41321526 |
| 125 | KSR2 | 0.41215711 |
| 126 | RPS6KA6 | 0.40782559 |
| 127 | CDK6 | 0.40513692 |
| 128 | STK38 | 0.40460017 |
| 129 | MAP3K2 | 0.39990016 |
| 130 | ABL1 | 0.38488524 |
| 131 | IGF1R | 0.38237782 |
| 132 | MTOR | 0.37919670 |
| 133 | MOS | 0.36223864 |
| 134 | FES | 0.35379147 |
| 135 | FGFR3 | 0.35057650 |
| 136 | MAP3K7 | 0.33657436 |
| 137 | MAPK11 | 0.32694751 |
| 138 | PIM1 | 0.31121529 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.44632839 |
| 2 | * Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.28851086 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.16915122 |
| 4 | * Lysosome_Homo sapiens_hsa04142 | 2.75182315 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.68721965 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.48985966 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.35937617 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.29595517 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.01976613 |
| 10 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.98037371 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.87416816 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.60882998 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.60067809 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.58720726 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.49671827 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.49248598 |
| 17 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.47391649 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.45787296 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.44689240 |
| 20 | Bladder cancer_Homo sapiens_hsa05219 | 1.39130698 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.38274754 |
| 22 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34374652 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.32151011 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.26749081 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.26182689 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.25740264 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.17522820 |
| 28 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.17131535 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.16758260 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.16535420 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16175197 |
| 32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.14676249 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.11773555 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.10077393 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.06781237 |
| 36 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.06499042 |
| 37 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.06420699 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 1.05915665 |
| 39 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.03314519 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.02980272 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.01781248 |
| 42 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.00248872 |
| 43 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.99864730 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 0.98799264 |
| 45 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.97309196 |
| 46 | Galactose metabolism_Homo sapiens_hsa00052 | 0.97116870 |
| 47 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.96704378 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 0.96295084 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.95658730 |
| 50 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.95543726 |
| 51 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.94730478 |
| 52 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.93836295 |
| 53 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.93493863 |
| 54 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.93218583 |
| 55 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.92893860 |
| 56 | Prion diseases_Homo sapiens_hsa05020 | 0.91889447 |
| 57 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90658931 |
| 58 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.87116611 |
| 59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82894179 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.82505548 |
| 61 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.80146355 |
| 62 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.78197655 |
| 63 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.77741115 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.77109979 |
| 65 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.76606152 |
| 66 | Amoebiasis_Homo sapiens_hsa05146 | 0.76288228 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 0.74777087 |
| 68 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.74046619 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.74013591 |
| 70 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.73382022 |
| 71 | Carbon metabolism_Homo sapiens_hsa01200 | 0.73162383 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70736021 |
| 73 | Sulfur relay system_Homo sapiens_hsa04122 | 0.68891622 |
| 74 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.68849873 |
| 75 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.68594857 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67776191 |
| 77 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.67653007 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67645427 |
| 79 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.67505363 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.67119096 |
| 81 | Salmonella infection_Homo sapiens_hsa05132 | 0.66727330 |
| 82 | Retinol metabolism_Homo sapiens_hsa00830 | 0.66478925 |
| 83 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.63952883 |
| 84 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.63692815 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63537223 |
| 86 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.62425980 |
| 87 | Lysine degradation_Homo sapiens_hsa00310 | 0.60381179 |
| 88 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59604206 |
| 89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59013394 |
| 90 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58730458 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.58667610 |
| 92 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.57471539 |
| 93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57214433 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.57056701 |
| 95 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.56295314 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.55716032 |
| 97 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.55559994 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.55544765 |
| 99 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.55454194 |
| 100 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.55225625 |
| 101 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.53722851 |
| 102 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53231820 |
| 103 | Measles_Homo sapiens_hsa05162 | 0.52340790 |
| 104 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51225936 |
| 105 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50305846 |
| 106 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50061110 |
| 107 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49969007 |
| 108 | Hepatitis B_Homo sapiens_hsa05161 | 0.49158974 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48752267 |
| 110 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47910187 |
| 111 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.47591713 |
| 112 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47585345 |
| 113 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46614680 |
| 114 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46608031 |
| 115 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.46002284 |
| 116 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.45798461 |
| 117 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.44605400 |
| 118 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.44352196 |
| 119 | Endocytosis_Homo sapiens_hsa04144 | 0.44232244 |
| 120 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43938509 |
| 121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43808582 |
| 122 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42572643 |
| 123 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42466805 |
| 124 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.40252848 |
| 125 | Influenza A_Homo sapiens_hsa05164 | 0.39619687 |
| 126 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39039835 |
| 127 | Shigellosis_Homo sapiens_hsa05131 | 0.38684203 |
| 128 | Focal adhesion_Homo sapiens_hsa04510 | 0.37960760 |
| 129 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37719819 |
| 130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37073369 |

